Molecular Partners AG is a clinical-stage biopharmaceutical company based in Schlieren, Switzerland. Founded in 2004 as a spin-off from the University of Zürich, the company specializes in developing DARPin therapeutics, a unique class of small proteins designed to address unmet medical needs in oncology, immuno-oncology, ophthalmology, and infectious diseases. The company's core offering is i...